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Abstract 
Problem/Condition: Cryptosporidiosis is a nationally notifiable gastrointestinal illness caused by chlorine-tolerant 
protozoa of the genus Cryptosporidium. 
Reporting Period: 2006–2008. 
System Description: State and two metropolitan health departments voluntarily report cases of cryptosporidiosis 
through CDC’s National Notifiable Diseases Surveillance System. 
Results: During 2006–2008, the number of reported cases of cryptosporidiosis increased dramatically (79.9%), from 
6,479 for 2006 to 11,657 for 2007, and then decreased (9.9%) to 10,500 in 2008. All jurisdictions reported cryptospo-
ridiosis cases during the reporting period, and the number of jurisdictions reporting >2.5 cases per 100,000 population 
increased from 20 in 2006 to 26 in 2007 and 27 in 2008. A greater number of case reports were received for children 
aged 1–9 years and for adults aged 25–39 years than were received for persons in other age groups. The number of cases 
reported among males and females was similar. Racial and ethnic comparisons were difficult because many case-reports 
did not report race and ethnicity. Peak onset of illness occurred annually during early summer through early fall. 
Interpretation: Transmission of cryptosporidiosis occurs throughout the United States, with more frequent diagnosis 
or reporting occurring in northern states. An increase in cases reported for 2007 and 2008 is attributable partially to 
multiple large recreational water-associated outbreaks. State incidence figures should be compared with caution because 
individual state surveillance systems have varying capabilities to detect cases, and reporting might vary. The seasonal 
peak in age-specific case reports coincides with the summer recreational water season and likely reflects increased use of 
communal swimming venues (e.g., lakes, rivers, swimming pools, and water parks) by young children. 
Public Health Action: Local and state health departments can use cryptosporidiosis surveillance data to better under-
stand the epidemiologic characteristics and the disease burden of cryptosporidiosis in the United States, design efforts 
to prevent the spread of disease, and establish research priorities. 
Introduction
Cryptosporidiosis is a gastrointestinal illness caused by 
protozoa of the genus Cryptosporidium (1). In otherwise 
healthy persons, clinical illness is characterized by watery 
diarrhea, which can be accompanied by abdominal cramps, 
loss of appetite, low-grade fever, nausea, vomiting, and weight 
loss; however, asymptomatic infection occurs frequently (2). 
Cryptosporidium also can cause an opportunistic infection in 
human immunodeficiency virus (HIV)–infected patients, 
who might experience life-threatening infection with profuse, 
watery, cholera-like diarrhea. In severely immunocompromised 
patients, disease can progress to cholangitis or pancreatitis (3). 
However, incidence of this parasitic infection among the HIV-
infected population has decreased since the introduction of 
highly active antiretroviral therapy (HAART) for HIV infec-
tion (4). Nitazoxanide is the only broad-spectrum antiparasitic 
drug that has been approved in the United States for treatment 
of cryptosporidiosis. Nitazoxanide can be prescribed for chil-
dren aged >1 year and adults, but it has not proven effective 
for immunocompromised persons (5,6).
Cryptosporidium is a genus of protozoan parasites within the 
phylum Apicomplexa, and its taxonomy continues to evolve. 
Cryptosporidiosis is a zoonotic disease that causes clinical 
disease in both humans and animals; species names are based 
primarily on the animal species serving as host (7). Revised 
Cryptosporidium taxonomy based on recent advances in molecu-
lar laboratory testing methods has clarified that multiple species 
infect humans. C. hominis (known previously as C. parvum geno-
type I) primarily infects humans and exists in a human-to-human 
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transmission cycle. C. parvum (known previously as C. parvum 
genotype II) can infect both humans and ruminants, each with 
their own transmission cycles that intersect in zoonotic disease. 
In addition, molecular studies have demonstrated that humans 
are susceptible to infection with multiple subtypes of C. parvum 
and C. hominis (7). To a lesser extent, human infections also have 
been documented with C. felis, from cats; C. canis, from dogs; 
C. meleagridis, from birds; C. suis, from pigs; C. muris, from 
rodents; and a C. cervine genotype from various animals (7). 
Illnesses caused by infection with the different Cryptosporidium 
species might differ clinically (8). 
Cryptosporidium infection is transmitted by the fecal-oral 
route and results from the ingestion of Cryptosporidium oocysts 
through the consumption of fecally contaminated food or 
water or through direct person-to-person or animal-to-person 
contact. The oocysts are infectious immediately upon being 
excreted in feces. The infectious dose is low; feeding studies 
have demonstrated that the ingestion of as few as 10–30 oocysts 
can cause infection in healthy persons (9,10). Infected persons 
have been reported to shed 108–109 oocysts in a single bowel 
movement and to excrete infectious oocysts for up to 50 days 
after cessation of diarrhea (11,12).
Cryptosporidium can exist in a body of water treated with 
chlorine (i.e., it is chlorine tolerant), which poses challenges 
for traditional chemical treatment of drinking and recreational 
water and for environmental surface cleaning. The organism 
also is not easily inactivated by alcohol-based hand sanitizers. 
Prevention and control measures include 1) practicing good 
hygiene (e.g., washing hands and not swimming when ill 
with diarrhea), 2) treating or avoiding contaminated water 
(not swallowing pool water, boiling or filtering water, and 
installing secondary disinfection systems (e.g., ultraviolet 
irradiation or ozone disinfection systems that inactivate 
Cryptosporidium) in pools, 3) exercising caution when traveling, 
and 4) avoiding fecal exposure during sexual activity (13). 
Although cryptosporidiosis cases occur sporadically, outbreaks 
have been well documented since the first reported U.S. drinking 
water-associated outbreak in 1984 (14) and the first U.S. recre-
ational water-associated outbreak in 1988 (15). Cryptosporidium 
has since emerged as the most frequently recognized cause of 
recreational water-associated outbreaks of gastroenteritis, par-
ticularly in treated (disinfected) venues. In addition, foodborne 
outbreaks of cryptosporidiosis linked to ill food handlers and 
unpasteurized apple cider have been reported (16,17). Outbreaks 
resulting from person-to-person transmission in child care 
centers and from animal-to-person transmission in an animal 
nursery also have been reported (18,19).
In 1994, the Council of State and Territorial Epidemiologists 
called for reporting of cryptosporidiosis as a nationally 
notifiable disease; the first full year for reporting began in 
1995. Surveillance data for 1995–2005 have been published 
previously (20–22). This report summarizes national crypto-
sporidiosis surveillance data for 2006–2008.
Methods
Case Definition
Confirmed and probable cases of cryptosporidiosis are 
reported voluntarily to CDC. A confirmed case of cryptospori-
diosis (i.e., one that has a positive laboratory finding) is defined 
as one in which Cryptosporidium has been detected in
organisms in stool, intestinal fluid, or tissue samples or •	
biopsy specimens;
antigens in stool or intestinal fluid; or •	
nucleic acid in stool, intestinal fluid, or tissue samples or •	
biopsy specimens (23,24).
A probable case of cryptosporidiosis is a clinically compat-
ible case that is linked epidemiologically to a confirmed case 
(23). This report includes both confirmed and probable cases 
as reported by jurisdictions.
testing
Testing for Cryptosporidium is not always included in routine 
examination of stool for ova and parasites (1). Commercially 
available immunoassay kits are available and might be more 
sensitive and specific than routine microscopic examination 
(25). Direct fluorescent antibody (DFA) testing is an extremely 
sensitive and specific detection method and is considered the 
“gold standard” by many laboratorians; other immunodiagnostic 
kits that do not require microscopy (e.g., enzyme immunoas-
say [EIA] testing and rapid immunochromatographic cartridge 
assays) also are available (25); they do not take the place of routine 
ova and parasite examination but might be useful in diagnosing 
Cryptosporidium infections. Only molecular testing (e.g., poly-
merase chain reaction) can be used to speciate Cryptosporidium; 
however, no species data are reported to CDC.
Reporting
State, District of Columbia (DC), and New York City (NYC) 
health department jurisdictions report cases of cryptosporidiosis 
to CDC voluntarily through the National Notifiable Diseases 
Surveillance System (NNDSS). Reports include the patient’s place 
of residence (i.e., state and county), age, sex, race, ethnicity (i.e., 
Hispanic or non-Hispanic) and date of illness onset and indicate 
whether the case is linked to a known outbreak. An outbreak-
associated case is a laboratory-confirmed or probable case that 
is linked epidemiologically to an outbreak. Because this report 
includes probable cases of cryptosporidiosis, and because some of 
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the data were finalized more recently, the number of cases provided 
in this report might be slightly higher than the number reported 
in CDC’s annual Summary of Notifiable Diseases. 
Analysis
Analysis of national cryptosporidiosis surveillance data for 
2006–2008 was conducted using SAS v.9.1 (SAS Institute 
Inc.; Cary, North Carolina) and the Food Safety Information 
Link (FSI Link). FSI Link is an intranet-based tool available 
to CDC staff that provides access to NNDSS data and is used 
to monitor trends in, and investigate outbreaks of, reportable 
foodborne and waterborne diseases. Population data from the 
U.S. Census Bureau were used to calculate incidence rates.
Results
During 2006–2008, the number of reported cases of cryp-
tosporidiosis increased dramatically (79.9%), from 6,479 for 
2006 to 11,657 for 2007, and then decreased (9.9%) to 10,500 
in 2008 (Table 1). All jurisdictions reported cryptosporidiosis 
cases during the reporting period, and the number of jurisdic-
tions reporting ≥2.5 cases per 100,000 population increased 
from 20 in 2006 to 26 in 2007 and 27 in 2008 (Table 1).
During 2006–2008, incidence of cryptosporidiosis per 
100,000 population ranged from 0.2 cases (in Hawaii, 2008) to 
71.2 cases (in Utah, 2007) (Table 1; Figure 1). The higher inci-
dence of cryptosporidiosis in Utah in 2007 was influenced by 
a single large outbreak among >1,900 persons (26). Increased 
reporting of cases also occurred in certain Midwestern, Rocky 
Mountain, and Southwestern states.
Surveillance data displayed a bimodal age distribution, 
with the greatest number of reported cases occurring among 
children aged 1–9 years and among adults aged 25–39 years 
(Figure 2). When reports for which a patient’s sex was unknown 
or missing were excluded, the percentage of cases reported to 
have occurred among males remained consistent at 51.2% 
(3,293 of 6,421) for 2006, 49.6% (5,745 of 11,582) for 2007, 
and 49.7% (5,181 of 10,415) for 2008 (Table 2).
The majority of cases for which data on race were available 
for 2006–2008 occurred among whites, followed by blacks, 
Asians/Pacific Islanders, and American Indians/Alaska Natives 
(Table 2). However, data on race were lacking for 26.7%–32.5% 
of total annual case reports. Of patients for whom data on ethnic-
ity were reported, 9.4%–15.4% were reported to be Hispanic 
(Table 2). However, data on ethnicity were lacking for 38%–44% 
of total annual case reports for 2006–2008.
A tenfold increase in reported cryptosporidiosis cases by ill-
ness onset date occurred during June–October compared with 
January–March (Figure 3). Age-specific analysis indicated that the 
seasonality in onset of illness was exhibited across all age groups, 
particularly among children aged 1–4 and 5–9 years (Figure 4).
The increase in cryptosporidiosis cases reported during 
2006–2008 is a continuation of the fourfold increase in 
cryptosporidiosis since 2005 (Figure 5). This coincides with a 
similar dramatic rise in the number of cryptosporidiosis out-
breaks associated with recreational water (Figure 6). During 
1988–2006, Cryptosporidium was identified as the causal 
agent of 41.8% (100 of 239) of reported recreational water-
associated outbreaks and of 5.7% (13 of 229) of reported 
drinking water-associated outbreaks of gastroenteritis in the 
United States (15,27–39). 
Discussion
National cryptosporidiosis surveillance data are used to assess 
the epidemiologic characteristics and disease burden of cryptospo-
ridiosis in the United States. The total number of cases reported 
annually and disease incidence increased during 2006–2008 and 
has increased dramatically since 2004 (Figures 1 and 5). Whether 
this increase reflects changes in reporting patterns and diagnostic 
testing practices or an actual change in infection and disease caused 
by Cryptosporidium is unclear but was clearly influenced by out-
break-related case reporting (Figure 6). However, outbreak-related 
probable case reporting does not account for the entire increase 
in reporting (Table 1). This increase also follows the introduction 
of nitazoxanide, the first licensed treatment for the disease, which 
was licensed in 2002 for children aged 1–11 years and in 2004 for 
children aged >11 years and adults (5). Because treatment for cryp-
tosporidiosis now is available, health-care providers might be more 
willing to request Cryptosporidium testing, leading to an increase 
in subsequent case reports. However, no data exist to support this 
hypothesis. The geographic variation, age distribution, and late-
summer through early-fall seasonality were consistent with previous 
cryptosporidiosis surveillance summaries (20–22).
Cryptosporidiosis is widespread geographically in the United 
States. Whereas previous surveillance data indicated that the 
diagnosis or reporting of cryptosporidiosis might be higher in 
northern or midwestern states (20–22), data from 2006–2008 
seem to indicate that cryptosporidiosis incidence has increased 
in all states in recent years (Figure 1). Interpretation of this 
observation is difficult, and whether this change reflects an 
improvement in the diagnostics or detection by reporting 
systems of those states or represents an actual increase in the 
number of cases is unclear. Varying crypto sporidiosis surveil-
lance systems and differences in reporting among states might 
affect the capability to detect and report cases.
Although cryptosporidiosis affects persons in all age groups, 
the number of reported cases was highest among children 
aged 1–9 years and adults aged 25–39 years (Figure 2). These 
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TABLE 1. Number and percentage* of cryptosporidiosis case reports, by state/area — National Notifiable Disease Surveillance 
System, United States,† 2006–2008
2006 2007 2008
State/Area No. (%) Rate§
No. 
outbreak 
cases¶ No. (%) Rate
No. 
outbreak 




Alabama 72 (1.1) 1.5 126 (1.1) 2.7 9 74 (0.7) 1.6
Alaska 4 (0.1) 0.6 4 (0.0) 0.6 3 (0.0) 0.4
Arizona 29 (0.4) 0.4 53 (0.5) 0.8 89 (0.8) 1.4
Arkansas 29 (0.4) 1.0 63 (0.5) 2.2 95 (0.9) 3.3
California 340 (5.2) 0.9 303 (2.6) 0.8 275 (2.6) 0.7
Colorado 77 (1.2) 1.6 10 216 (1.9) 4.5 10 113 (1.1) 2.3 1
Connecticut 38 (0.6) 1.1 42 (0.4) 1.2 41 (0.4) 1.2
Delaware 15 (0.2) 1.7 21 (0.2) 2.4 12 (0.1) 1.4
District of Columbia 17 (0.3) 2.9 3 (0.0) 0.5 15 (0.1) 2.5
Florida 717 (11.1) 3.9 219 738 (6.3) 4.1 115 549 (5.2) 3.0 72
Georgia 275 (4.2) 2.8 239 (2.1) 2.5 263 (2.5) 2.7
Hawaii 4 (0.1) 0.3 6 (0.1) 0.5 2 (0.0) 0.2
Idaho 40 (0.6) 2.6 518** (4.4) 34.6 365 73 (0.7) 4.8 5
Illinois 257 (4.0) 2.0 66 205 (1.8) 1.6 17 207 (2.0) 1.6
Indiana 113 (1.7) 1.8 149 (1.3) 2.4 203 (1.9) 3.2 1
Iowa 231 (3.6) 7.7 610 (5.2) 20.4 284 (2.7) 9.5
Kansas 82 (1.3) 2.9 155 (1.3) 5.6 38 84 (0.8) 3.0 4
Kentucky 44 (0.7) 1.0 249 (2.1) 5.9 179 36 (0.3) 0.8
Louisiana 86 (1.3) 1.9 64 (0.5) 1.5 67 (0.6) 1.5
Maine 52 (0.8) 3.9 4 56 (0.5) 4.3 7 46 (0.4) 3.5 7
Maryland 20 (0.3) 0.4 36 (0.3) 0.6 54 (0.5) 1.0
Massachusetts 175 (2.7) 2.7 5 132 (1.1) 2.0 172 (1.6) 2.6
Michigan 145 (2.2) 1.4 1 215 (1.8) 2.1 284 (2.7) 2.8
Minnesota 242 (3.7) 4.6 12 303 (2.6) 5.8 14 236 (2.2) 4.5 6
Mississippi 25 (0.4) 0.9 103 (0.9) 3.5 17 (0.2) 0.6
Missouri 283 (4.4) 4.8 214 (1.8) 3.6 195 (1.9) 3.3
Montana 152 (2.3) 15.7 46 77 (0.7) 8.0 45 (0.4) 4.7
Nebraska 115 (1.8) 6.4 1 196 (1.7) 11.1 2 113 (1.1) 6.3 11
Nevada 14 (0.2) 0.5 37 (0.3) 1.4 17 (0.2) 0.7 4
New Hampshire 47 (0.7) 3.6 47 (0.4) 3.6 1 61 (0.6) 4.6
New Jersey 42 (0.6) 0.5 1 67 (0.6) 0.8 1 40 (0.4) 0.5
New Mexico 45 (0.7) 2.3 125 (1.1) 6.4 242 (2.3) 12.2 93
New York†† 339 (5.2) 1.7 1 359 (3.1) 1.8 4 376 (3.6) 1.9
 New York City 155 (2.4) 1.9 105 (0.9) 1.3 107 (1.0) 1.3
North Carolina 101 (1.6) 1.1 7 132 (1.1) 1.5 10 79 (0.8) 0.9 3
North Dakota 20 (0.3) 3.1 78 (0.7) 12.2 16 (0.2) 2.5
Ohio 369 (5.7) 3.2 8 608 (5.2) 5.3 16 705 (6.7) 6.1 48
Oklahoma 56 (0.9) 1.5 216 (1.9) 6.0 104 238 (2.3) 6.5 44
Oregon 82 (1.3) 2.2 9 163 (1.4) 4.4 38 69 (0.7) 1.8 4
Pennsylvania 287 (4.4) 2.3 17 1,023** (8.8) 8.2 488 331 (3.2) 2.7 9
Rhode Island 14 (0.2) 1.3 11 (0.1) 1.0 10 (0.1) 1.0 1
South Carolina 131 (2.0) 2.9 44 88 (0.8) 2.0 60 (0.6) 1.3
South Dakota 86 (1.3) 10.7 5 169 (1.4) 21.2 3 88 (0.8) 10.9 6
Tennessee 48 (0.7) 0.8 141 (1.2) 2.3 5 48 (0.5) 0.8 1
Texas 273 (4.2) 1.1 37 235 (2.0) 1.0 2 3,342** (31.8) 13.7 1,709
Utah 21 (0.3) 0.8 1,901** (16.3) 71.2 1,901 49 (0.5) 1.8
Vermont 54 (0.8) 8.7 47 (0.4) 7.6 64 (0.6) 10.3
Virginia 71 (1.1) 0.9 90 (0.8) 1.2 81 (0.8) 1.0
Washington 95 (1.5) 1.5 151 (1.3) 2.3 8 99 (0.9) 1.5
West Virginia 20 (0.3) 1.1 12 (0.1) 0.7 26 (0.2) 1.4
Wisconsin 532 (8.2) 9.5 26 790 (6.8) 14.1 786 (7.5) 14.0
Wyoming 53 (0.8) 9.9 71 (0.6) 13.6 35 26 (0.2) 4.9 2
Total 6,479 (100.0) 2.2 519 11,657 (100.0) 3.9 3,372 10,500 (100.0) 3.5 2,031
Sources: Population estimates are from the Population Division, U.S. Census Bureau. Annual estimates of the resident population for the United States, regions  states,  and Puerto 
Rico:  July 1, 2000 to July 1, 2008 (NST-EST 2008 01). Available at http://www.census.gov/popest/states. Estimates of the New York City population are from Annual estimates 
of the population for incorporated places over 100,000, ranked by July 1, 2008 population:  April 1, 2000 to July 1, 2008 (SUB-EST 2008-01). Available at http://www.census.gov/
popest/cities/tables. 
 * Percentages might not total 100% because of rounding.
 † Cryptosporidiosis is not a reportable condition in U.S. territories or freely associated states.
 § Per 100,000 population on the basis of U.S. Census Bureau population estimates.
 ¶ Number of cases linked to a known outbreak.
 ** Includes cases from large recreational water outbreaks.
 †† New York State case reports include New York City.
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data are consistent with reports of cryptosporidiosis incidence 
being higher among younger children and of transmission 
to their caregivers (e.g., child care staff, family members, 
and other household contacts) (18,20,21,40,41). Because 
information regarding immune system status is not collected 
as part of NNDSS crypto sporidiosis reporting, the number 
of immunosuppressed persons aged 25–39 years included in 
these surveillance data is unknown. However, the introduc-
tion of HAART therapy for persons with AIDS has decreased 
the incidence of cryptosporidiosis and the amount of severe 
cryptosporidiosis being diagnosed among persons with AIDS 
in the United States (4,42).
The tenfold increase in onset of cryptosporidiosis occurring 
during summer through early fall (Figure 3) is not unexpected. 
This increase coincides with increased swimming activities dur-
ing the summer recreational water season and likely reflects 
the contribution of recreational water venues in the transmis-
sion of Cryptosporidium, particularly among younger children 
(15,27,29,31–38,43). Cryptosporidium is the leading cause of 
reported recreational water-associated outbreaks of gastroenteritis 
(38). Transmission through recreational water is facilitated by the 
substantial number of Cryptosporidium oocysts that can be shed 
by a single person; the extended periods of time that oocysts can 
be shed (11,12); the low infectious dose (9,10); the tolerance of 
Cryptosporidium oocysts to chlorine (44); and the prevalence of 
improper pool maintenance (i.e., insufficient disinfection, filtra-
tion, and recirculation of water), particularly of children’s wading 
pools (45). This seasonal variation also has been noted in state, 
Canadian provincial, and previous U.S. national surveillance data 
for cryptosporidiosis and giardiasis (20–22,40,41,46–48).
The marked seasonal variation, higher incidence among 
children, and link to recreational water use for cryptospori-



























* Per 100,000 population.
† Source: Yoder JS, Beach MJ. Cryptosporidiosis surveillance—United States, 2003–2005. In: Surveillance Summaries, September 7, 2007. MMWR 2007;56(No. 
SS-7):1–10.
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diosis is highlighted by the large communitywide outbreak 
in Utah in 2007 (26). The Utah Department of Health 
reported 1,901 confirmed cryptosporidiosis cases during 
June–December 2007, compared with the state’s normal 
annual median of 16 confirmed cases. The full magnitude 
of the outbreak was likely much larger as investigations were 
limited to laboratory-confirmed cases. Epidemiologic studies 
implicated multiple recreational water venues as the source 
of this outbreak, and 80% of patients reported attending 
recreational water venues within 14 days of illness onset. In 
addition, 20% of patients reported swimming while ill with 
diarrhea, which implicated recreational water venues as an 
ongoing source of Cryptosporidium transmission. Children aged 
<5 years represented 32% of patients (median age: 9 years). 
After the infection rate peaked in mid-August, with nearly 60 
confirmed cases of reported onset of illness on a single day, the 
Utah Department of Health further intensified control efforts, 
including hyperchlorination of pools and banning of children 
aged <5 years from community pools. Disease incidence rates 
began to decline after the stricter control measures and then 
continued to decline with the closing of seasonal pools in 
September. As the outbreak progressed, more patients reported 
having no recreational water exposure but had contact with 
persons who were ill with diarrhea. This finding supports a 
role for secondary person-to-person transmission in commu-
nitywide outbreaks. The lack of appropriate stool specimens 
prevented genotyping, which would have aided in determin-
ing chains of transmission. Although the water venues were 
filtered and chlorinated, the treatment was not sufficient to 
inactivate Crypto sporidium, which is highly chlorine tolerant. 
After implementation of hyperchlorination and banning of 
potentially incontinent children from swimming, followed by 
the closure of community pools at the end of the season, the 
outbreak began to decline. For 2008, Utah launched an edu-
cation effort for swimmers and pool operators using multiple 
media combined with  enhanced cryptosporidiosis surveillance 




















* N = 28,636; age for 332 case-patients was unknown.
FIGURE 3. Number* of cryptosporidiosis case reports, by date 
of illness onset — National Notifiable Disease Surveillance 
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* N = 28,636; date of onset for 7,017 case-patients was unknown.
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and prevention efforts; only 49 cryptosporidiosis cases were 
reported in 2008 (Table 1).
Outbreak reports reflecting the multiple routes of transmis-
sion for Cryptosporidium also were reported during 2006–2008. 
Twelve cryptosporidiosis outbreaks associated with food, animal 
contact, or person-to-person transmission were reported to 
CDC during this period; these outbreaks affected >125 persons 
(49,50). Six outbreaks were associated with animal exposure, 
three involved unknown exposure in the home, one was associ-
ated with a restaurant, and one was associated with a child care 
facility. The remaining outbreak involved increased reporting of 
cryptosporidiosis cases in Colorado, which involved multiple 
risk factors. Investigation determined that ill persons were more 
likely to have swallowed untreated water from a lake, river, or 
stream; have had exposure to recreational water; or have had 
contact with a child in a child care program or in diapers (51). 
Cryptosporidiosis (as with all diseases caused by enteric 
pathogens) is likely underreported because 1) not all infected 
persons are symptomatic, 2) those who are symptomatic do 
not always seek medical care (52,53), 3) health-care providers 
infrequently include laboratory diagnostics in their evaluation 
of nonbloody diarrheal diseases (52), 4) the majority of physi-
cians do not specifically request testing for Cryptosporidium as 
part of ova and parasite testing (54), 5) a majority of labora-
tories do not test for Cryptosporidium unless it is specifically 
requested (55), and 6) case-reports are not always completed 
for positive laboratory results or forwarded to public health 
officials (56). The licensing of the first treatment for cryptospo-
ridiosis (5) might influence health-care providers to request 
Cryptosporidium testing more often when ova and parasite 
exams are ordered. Its low infectious dose (9), protracted 
communicability (11,12), and chlorine tolerance (44) make 
Cryptosporidium ideally suited for transmission through drink-
ing and recreational water, food, and both person-to-person 
and animal-to-person contact. Several studies have character-
ized risk factors associated with Cryptosporidium. Persons at 
increased risk for infection include 1) those who have contact 
TABLE 2. Number and percentage* of cryptosporidiosis case reports, by selected demographic characteristics — National 
Notifiable Disease Surveillance System, United States 2006–2008
2006 2007 2008
Characteristic  No.  (%) No. (%) No.         (%)
Sex 
Male 3,293   (50.8)   5,745   (49.3) 5,181   (49.3)
Female 3,128  ( 48.3)   5,837  ( 50.1) 5,234   (49.9)
Unknown/Missing 58 (0.9)    75    (0.6) 85     (0.8)
Total 6,479 (100.0) 11,657 (100.0) 10,500 (100.0)
Race
American Indian/Alaska Native 31     (0.5) 73     (0.6) 41    (0.4)
Asian/Pacific Islander 66     (1.0) 84     (0.7) 92    (0.9)
Black 544     (8.4) 618     (5.3) 824    (7.9)
White 3,912   (60.4) 6,858   (58.8) 6,546  (62.3)
Other 170    (2.6) 358    (3.1) 190    (1.8)
Unknown/Missing 1,756   (27.1) 3,666   (32.5) 2,807  (26.7)
Total 6,479 (100.0) 11,657 (100.0) 10,500 (100.0)
Ethnicity
Hispanic 426     (6.6) 616     (5.3) 1,003    (9.6)
Non-Hispanic 3,472  (53.6) 5,909   (50.7) 5,503   (52.4)
Unknown/Missing 2,581   (39.8) 5,132  (44.0) 3,994   (38.0)
Total 6,479 (100.0) 11,657 (100.0) 10,500 (100.0)
* Percentages might not total 100% because of rounding.
FIGURE 4. Number* of cryptosporidiosis case reports, by selected 
age group† and date of illness onset — National Notifiable 
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* N = 9,166. 
† The 1–4- and 5–9-year age groups are presented because they have the 
highest numbers of cryptosporidiosis case reports and have the greatest 
seasonality. The 30–34-year age group was chosen to illustrate the less 
pronounced seasonality of the other age groups.
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with infected animals, 2) those who have ingested contami-
nated recreational (e.g., lake, river, pool, or hot tub) or drink-
ing water, 3) close contacts of infected persons (e.g., those in 
the same family or household or in child care settings), and 4) 
travelers to disease-endemic areas (1,43,57–59).
In recent years, three studies conducted in the United 
States, the United Kingdom, and Australia used multivari-
ate analysis to identify risk factors associated with sporadic 
cryptosporidiosis. The important risk factors found in these 
studies included contact with persons with diarrhea, particu-
larly incontinent persons such as young children, and contact 
with cattle, especially calves (43,58,59). The U.S. (43) and 
U.K. (59) studies also identified travel abroad as a risk factor 
whereas the Australian (58) study excluded persons who had 
recently traveled abroad to better characterize endemic disease. 
In addition, the U.S. study identified swimming in fresh water 
as a risk factor for becoming ill with cryptosporidiosis, and the 
U.K. and Australian studies identified drinking unboiled water 
from rural sources as a risk factor.
Several additional studies have identified contact with cattle 
as a significant risk factor for sporadic cryptosporidiosis. During 
a foot-and-mouth disease outbreak in the United Kingdom in 
2001, millions of animals were slaughtered, and access to the 
countryside was restricted. During this time, the counties with 
the heaviest restrictions experienced an 82% reduction in the 
number of cryptosporidiosis cases reported, particularly in the 
transmission peak temporally corresponding with the spring 
calving season, suggesting an association between cattle con-
tact and human disease in the United Kingdom (60). During 
2003–2005, genotyping was performed on samples from 
49 sporadic human cases of cryptosporidiosis in Wisconsin. 
Zoonotic genotypes C. parvum and the cervine type were 
identified in 46 of 49 cases. Nine different subgenotypes of 
C. parvum were identified, all of which had been previously 
identified in cattle in the surrounding region (61). Wisconsin 
has a high rate of cryptosporidiosis disease, but very few cases 
are associated with outbreaks (Table 1). Sporadic cryptospori-
diosis caused by zoonotic transmission from cattle is the likely 
main cause of this disease in Wisconsin (61). 
Non–C. parvum or C. hominis Cryptosporidium species are asso-
ciated less frequently with human infection. The avian pathogen 
C. meleagridis is emerging as an important zoonotic pathogen in 
immune-competent individuals in some communities. In Peru, 
where a significant number of infections are attributable to zoonotic 
transmission, 10%–20% of infections are caused by C. meleagridis 
(62). However, C. meleagridis is detected rarely in immune-com-
petent patients in industrialized countries (63, 64).
Cryptosporidium cannot multiply in food, so transmission 
of the parasite through food usually occurs through direct 
contamination of the food by an ill person or fecal contamina-
tion caused by improper hygiene practices during food pro-
duction, processing, or preparation. Limited outbreaks have 
been associated with nonpasteurized apple cider made from 
improperly cleaned fruit that was exposed to cattle feces in the 
orchard (17,65). A 1998 outbreak involving 88 persons in the 
District of Columbia was traced back to contaminated food 
that had been handled by a cafeteria worker who was sick with 
cryptosporidiosis (16). The food handler had recently spent 
some time with a young relative who was sick with vomiting 
and diarrhea and another relative who also had become ill 
with the same symptoms (16). Cryptosporidium oocysts have 
been detected on produce at markets (66,67). These vegetables 
were likely contaminated by Cryptosporidium-contaminated 
water used for irrigation or by the feces of wild animals with 
access to the fields (68,69). Despite the possibility of produce 
contamination at the farm level, the link between detection of 
Cryptosporidium on fresh produce and human infection is not 
well understood (70). In contrast, case-control studies among 
persons with sporadic cryptosporidiosis cases have determined 
that consumption of raw vegetables, particularly carrots, is a 
protective factor (43,58,59). This finding might be explained 
by repeated exposures to the small amounts of Cryptosporidium 
on the vegetables providing a protective immunity or high fiber 
in the diet increasing gut motility and thereby preventing the 
oocysts from invading the intestinal mucosa (43). 
Water appears to be a more important transmission route 
for Cryptosporidium and frequently is implicated in cryptospo-
ridiosis outbreaks and in studies of sporadic cases (42,43) 
(Figure 6). Risk factors for cryptosporidiosis associated with 
treated recreational water include fecal accidents in the pool, 



















FIGURE 5. Incidence* of cryptosporidiosis, by year — 
National Notifiable Disease Surveil lance System, 
United States, 1995–2008†
* Per 100,000 population.
† N = 68,907.
§ First full year of national reporting.
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diapered toddlers in the pool, swimming while ill with diar-
rhea, and swallowing pool water (38,58). Risk factors for cryp-
tosporidiosis associated with drinking water include drinking 
large amounts of unboiled rural or well water and failure of 
treatment protocols for public water supplies (58). 
Although no formalized national plan exists for preventing 
cryptosporidiosis in the United States, multiple efforts are 
focused on reducing the transmission of the parasite through 
the two major routes of waterborne transmission. For drink-
ing water, the Environmental Protection Agency (EPA) has 
implemented multiple regulations designed to improve the 
safety of surface water (e.g., lakes and rivers) supplies, includ-
ing multiple regulatory changes following an outbreak of 
cryptosporidiosis in 1993 in Milwaukee, Wisconsin, that 
sickened >400,000 persons using the city water supply (34,71). 
Since 1993, no Cryptosporidium outbreaks associated with 
use of community surface water supplies have occurred in the 
United States (28,30–34,39). In addition, a study conducted 
during 1996–2004 in the United Kingdom suggests that 
improvements in drinking water treatment and source water 
protection might be responsible for decreasing the number of 
cryptosporidiosis cases in humans caused by C. parvum from 
ruminants (72,73). EPA is implementing the Groundwater 
Rule in an effort to decrease the risk associated with use of 
groundwater (well) supplies (39). This regulatory change 
might decrease the occurrence of Cryptosporidium outbreaks 
associated with groundwater use.
For recreational water, Cryptosporidium remains the leading 
cause of diarrheal illness outbreaks, especially in chlorinated 
venues (38). Recently, cryptosporidiosis outbreaks that began 
in treated recreational water venues have spread to community-
wide transmission in multiple venues (e.g., child care centers 
and schools) (26). In addition, limited outbreaks in child 
care centers or schools can be amplified into communitywide 
outbreaks by the use of recreational water by ill persons (74). 
To address these challenges, CDC has collaborated with state 
health departments to develop guidelines for rapidly imple-
menting community control measures when a cryptosporidiosis 
outbreak is identified (26). Efforts to reduce the transmission of 
this chlorine-tolerant pathogen in pools will require a concerted 
effort to move beyond existing pool practices to include new 
secondary disinfection technology (ultraviolet light or ozone 
inactivation), operational improvements (use of filtration 
enhancements that improve Cryptosporidium removal), and 
public education to reduce continued swimming by persons 
who are ill with diarrhea. 
In the United States, no federal oversight of chlorinated 
swimming venues occurs. All pool codes are reviewed and 
approved by state or local public health officials. As a result, 
the United States has no uniform national standards govern-
ing the design, construction, operation, and maintenance of 
FIGURE 6. Number* of outbreaks of cryptosporidiosis associated with water, by water type — Waterborne Disease and Outbreak 
Surveillance System, United States, 1988–2008
* N = 172.
† Water that has undergone a treatment process (e.g., chlorination and filtration) to make it safe for recreation.
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swimming pools and other treated recreational water venues. 
To provide guidance and improve nationwide pool code 
uniformity, CDC is sponsoring an effort to develop a data-
driven, knowledge-based National Model Aquatic Health Code 
(available at http://www.cdc.gov/healthywater/swimming/
pools/mahc/). This effort involves state, local, and federal 
public health officials and the aquatics industry in creating a 
voluntary model regulatory structure for state and local health 
departments to use in developing pool codes. Health com-
munication efforts also should continue to educate swimmers 
about the hazards of swallowing pool water and swimming 
while ill with diarrhea.
Limitations
The data provided in this report are subject to certain limita-
tions, including likely underreporting of cases, lack of informa-
tion on race and ethnicity on most case reports, unknown HIV 
status, and lack of information on risk factors or attributable 
fractions by exposure types. Despite these limitations, these 
data provide the only national estimate of the number of cases 
of cryptosporidiosis that is available.
Conclusion
Continued efforts to reduce risk and improve diagnosis and 
reporting of cryptosporidiosis are needed to decrease the trans-
mission of cryptosporidiosis in the United States. Prevention 
measures (Box 1) and measures to improve surveillance and 
prevention for cryptosporidiosis and increase understanding 
of its epidemiology and the associated disease burden (Box 2) 
have been recommended. Additional information about cryp-
tosporidiosis epidemiology, diagnosis, treatment, prevention, 
and control is available at http://www.cdc.gov/crypto. 
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Additional information about cryptosporidiosis preven-
tion and control is available at http://www.cdc.gov/crypto/
gen_info/prevent.html. 
Avoid water that might be contaminated. 
Do not swallow water while swimming in swimming •	
pools, spas, interactive fountains, lakes, rivers, springs, 
ponds, streams, or the ocean.
Reduce  contamination of treated recreational water •	
venues by having pool operators install in-line second-
ary disinfection systems (e.g., ultraviolet light, ozone) to 
inactive this chlorine-tolerant parasite.
Do not drink untreated water from lakes, rivers, springs, •	
ponds, streams, or shallow wells.
Do not drink inadequately treated water or ice made •	
from water during communitywide outbreaks caused 
by contaminated drinking water.
Do not use or drink inadequately treated water or use •	
ice when traveling in countries where the water supply 
might be unsafe.
If the safety of drinking water is in doubt (e.g., outbreak, •	
poor sanitation, or lack of water treatment systems),
drink bottled water –
disinfect water by heating it to a rolling boil for 1  –
minute, or
use a filter that has been tested and rated by National  –
Safety Foundation (NSF) Standard 53 or NSF 
Standard 58 for cyst and oocyst reduction; filtered 
water will need additional treatment to kill or inac-
tivate bacteria and viruses. 
Additional information about water filters is available at 
http://www.cdc.gov/crypto/gen_info/filters.html. 
Avoid eating food that might be contaminated.
Use safe, uncontaminated water to wash all food that is •	
to be eaten raw.
After washing vegetables and fruit in safe, uncontami-•	
nated water, peel them before eating them raw. 
Avoid eating uncooked foods when traveling in countries •	
with poor water treatment and food sanitation.
Information about how to prevent illnesses while travel-
ing is available at http://wwwnc.cdc.gov/travel/content/
safe-food-water.aspx.
Prevent contact and contamination with feces during sex.
Use a barrier during oral-anal sex.•	
Wash hands immediately after handling a condom used •	
during anal sex and after touching the anus or rectal area.
Practice good hygiene.
Everywhere•	
Wash hands with soap and water for at least 20  –
seconds, rub hands together vigorously, and scrub 
all surfaces
before preparing or eating food, º
after using the toilet, º
after changing diapers or cleaning up a child who  º
has used the toilet,
before and after tending to someone who is ill  º
with diarrhea, and 
after handling an animal or its feces. º
Additional information about hygiene is available at http://
www.cdc.gov/healthywater/hygiene. 
At child care facilities•	
To reduce risk for disease transmission, exclude chil- –
dren with diarrhea from child care settings until the 
diarrhea has stopped.
At recreational water venues•	
Protect others by not swimming while experiencing  –
diarrhea (this is essential for children in diapers and 
aquatics staff). If cryptosporidiosis is diagnosed, do 
not swim for at least 2 weeks after diarrhea stops. 
Shower before entering the water. –
Wash children thoroughly (especially their bottoms)  –
with soap and water after they use the toilet or their 
diapers are changed and before they enter the water.
Take children on frequent bathroom breaks and check  –
their diapers often.
Change diapers in the bathroom, not at the  –
poolside.
Additional information about recreational water illnesses 
and how to stop them from spreading is available at http://
www.cdc.gov/healthywater/swimming.
Around animals•	
Minimize contact with the feces of all animals, par- –
ticularly young animals.
When cleaning up animal feces, wear disposable  –
gloves, and always wash hands when finished.
Wash hands after any contact with animals or their  –
living areas.
Outside•	
Wash hands after gardening, even if wearing gloves. –
Immunocompromised persons•	
Avoid close contact with anyone who has  –
cryptosporidiosis. 
Do not handle animal feces because infection can be  –
life threatening for immunocompromised persons.
BOX 1. CDC recommendations to prevent and control cryptosporidiosis
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Abstract 
Problem/Condition: Giardiasis is a nationally notifiable gastrointestinal illness caused by the protozoan parasite Giardia 
intestinalis. 
Reporting Period: 2006–2008. 
System Description: State, commonwealth, territorial, and two metropolitan health departments voluntarily report 
cases of giardiasis through CDC’s National Notifiable Disease Surveillance System. 
Results: During 2006–2008, the total number of reported cases of giardiasis increased slightly from 19,239 for 2006 
to 19,794 for 2007 and decreased slightly to 19,140 for 2008. During this period, 49 jurisdictions reported giardiasis 
cases; giardiasis is a reportable condition in 45 states (not reportable in Indiana, Kentucky, Mississippi, North Carolina, 
and Texas). A greater number of case reports were received for children aged 1–9 years and for adults aged 35–44 years 
compared with other age groups. Incidence of giardiasis was highest in northern states. Peak onset of illness occurred 
annually during early summer through early fall. 
Interpretation: Transmission of giardiasis occurs throughout the United States, with more frequent  diagnosis or report-
ing occurring in northern states. However, state incidence figures should be compared with caution because individual 
state surveillance systems have varying capabilities to detect cases. The seasonal peak in age-specific case reports coincides 
with the summer recreational water season and likely reflects increased outdoor activities and exposures such as camping 
and use of communal swimming venues (e.g., lakes, rivers, swimming pools, and water parks) by young children. 
Public Health Action: Local and state health departments can use giardiasis surveillance data to better understand 
the epidemiologic characteristics and the disease burden of giardiasis in the United States, design efforts to prevent the 
spread of disease, and establish research priorities. 
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Introduction
Giardia intestinalis (also known as G. lamblia and G. duode-
nalis) is the most common intestinal parasite of humans identi-
fied in the United States (1). This flagellated protozoan causes 
a generally self-limited clinical illness (i.e., giardiasis) typically 
characterized by diarrhea, abdominal cramps, bloating, weight 
loss, and malabsorption; asymptomatic infection also occurs 
frequently (2–4). Case reports have associated giardiasis with 
the development of chronic enteric disorders, allergies, and 
reactive arthritis (5–7). 
Giardia infection is transmitted by the fecal-oral route and 
results from the ingestion of Giardia cysts through the con-
sumption of fecally contaminated food or water or through 
person-to-person (or, to a lesser extent, animal-to-person) 
transmission. The cysts are infectious immediately upon being 
excreted in feces. The infectious dose is low; ingestion of 10 
cysts has been reported to cause infection (8). Infected persons 
have been reported to shed 108–109 cysts in their stool per day 
and to excrete cysts for months (8–10). Effective therapies are 
available for patients with symptomatic giardiasis, including 
metronidazole, nitazoxanide, tinidazole, paromomycin, fura-
zolidone, and quinacrine (11).
Giardia is distributed globally and has been detected in 
nearly all classes of vertebrates, including domestic animals 
and wildlife (12). Although G. intestinalis infects both humans 
and animals, the role of zoonotic transmission to humans and 
the importance of animal contamination of food and water 
are being re-examined. Recent advances in molecular epide-
miology have permitted identification of specialized genetic 
groups (i.e., assemblages) that are relatively species-specific. 
Assemblages A and B of G. intestinalis infect primarily humans 
and primates; assemblages C and D infect dogs, assemblage F 
infects cats, assemblage E infects hoofstock, and assemblage G 
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infects rodents (13). These findings suggest that G. intestinalis 
does not have as high a level of zoonotic disease transmission 
potential as thought previously (13). 
Persons at increased risk for infection include 1) travelers to 
disease-endemic areas, 2) children in child care settings, 3) close 
contacts of infected persons (e.g., those in the same family or 
household or in a child care setting), 4) persons who ingest con-
taminated drinking water, 5) persons who swallow contaminated 
recreational water (e.g., water in lakes, rivers, and pools), 6) persons 
taking part in outdoor activities (e.g., backpacking or camping) 
who consume unfiltered, untreated water or who fail to practice 
good hygienic behaviors (e.g., hand washing), 7) persons who 
have contact with infected animals, and 8) men who have sex with 
men (2,14–18). Giardiasis does not appear to be opportunistic in 
persons infected with human immunodeficiency virus. The relative 
contribution of person-to-person, animal-to-person, foodborne, 
and waterborne transmission to sporadic human giardiasis in the 
United States is not well understood.
Although giardiasis cases occur sporadically, outbreaks from 
multiple transmission routes are well documented. During 
1997–2006, Giardia was identified as a causal agent of six 
(3.7%) of 162 reported recreational water-associated gastroen-
teritis outbreaks and of 15 (10.6%) of 141 reported drinking 
water-associated gastroenteritis outbreaks in the United States 
(19–24). Worldwide, it is one of the most frequently identified 
parasites associated with waterborne disease outbreaks (25). 
Foodborne outbreaks of giardiasis are reported rarely. During 
1998–2007, of 7,650 foodborne outbreaks with an identified 
etiology, 15 (0.2%) were attributed to Giardia. (26). Improper 
hygiene practices have contributed to outbreaks of giardiasis 
associated with food (27), person-to-person transmission in 
child care centers (28), and communitywide outbreaks with 
waterborne and person-to-person transmission routes (29). 
Outbreaks associated with drinking water might be associated 
with animal contamination of water systems (30,31). However, 
the zoonotic transmission of giardiasis is not believed to play 
a major role in human disease (32).
In 1992, the Council of State and Territorial Epidemiologists 
assigned a reporting number for giardiasis (code 11570) to 
facilitate transmission of reported giardiasis data to CDC. 
Surveillance data for 1992–2005 have been published previ-
ously (33–35). Reporting of giardiasis as a nationally notifi-
able disease began in 2002. This report summarizes national 
giardiasis surveillance data for 2006–2008.
Methods
Case Definition
Confirmed and probable cases of giardiasis are reported 
voluntarily to CDC. A confirmed case of giardiasis (i.e., one 
that has a positive laboratory finding) is defined as the detec-
tion of Giardia intestinalis
cysts in stool specimens or trophozoites in stool specimens, •	
duodenal fluid, or small-bowel tissue by microscopic 
examination using staining methods (e.g., trichrome) or 
direct fluorescent antibody assays (DFA); or
antigens in stool specimens by immunodiagnostic testing •	
(e.g., enzyme-linked immunosorbent assay) (36).
A probable case of giardiasis is a clinically compatible case 
that is linked epidemiologically to a confirmed case (36).
testing
Because Giardia cysts can be excreted intermittently, multiple 
stool collections (i.e., three stool specimens collected every other 
day) increase test sensitivity (37). The use of concentration meth-
ods and trichrome staining might not be sufficient to identify 
Giardia because variability in the concentration of organisms 
in the stool can make this infection difficult to diagnose. For 
this reason, fecal immunoassays that are more sensitive and 
specific should be used (38). Direct fluorescent antibody (DFA) 
testing is an extremely sensitive and specific detection method 
and is considered the “gold standard” by many laboratorians; 
other immunodiagnostic kits that do not require microscopy 
(e.g., enzyme immunoassay [EIA] testing and rapid immuno-
chromatographic cartridge assays) also are available (38); they 
do not take the place of routine ova and parasite examination 
but might be useful in diagnosing Giardia infections. Only 
molecular testing (e.g., polymerase chain reaction [PRC]) can 
be used to subtype Giardia; however, no subtyping data are 
reported to CDC.
Reporting
Health departments in 45 states (all except Indiana, 
Kentucky, Mississippi, North Carolina, and Texas), the 
District of Columbia (DC), New York City (NYC), the 
Commonwealth of Puerto Rico, and Guam voluntarily report 
laboratory-confirmed and probable cases of giardiasis to CDC 
through the National Notifiable Disease Surveillance System 
(NNDSS). Reports include the patient’s place of residence (i.e., 
state and county), age, sex, race, ethnicity (i.e., Hispanic or 
non-Hispanic), and date of illness onset and indicate whether 
the case is linked epidemiologically to a known outbreak. 
Because this report includes probable cases of giardiasis, and 
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because certain data were finalized recently, the number of 
cases might differ slightly from the number reported in CDC’s 
annual Summary of Notifiable Diseases.
Analysis
Analysis of national giardiasis surveillance data for 2006–
2008 was conducted using SAS v.9.1 (SAS Institute, Inc.; Cary, 
North Carolina) and the Food Safety Information Link (FSI 
Link). FSI Link is an intranet-based tool available to CDC staff 
that provides access to NNDSS data and is used to monitor 
trends in and investigate outbreaks of reportable foodborne 
and waterborne diseases. Population data from the U.S. Census 
Bureau were used to calculate incidence rates.
Results
During 2006–2008, the total number of reported cases of 
giardiasis increased 2.9%, from 19,239 for 2006 to 19,794 
for 2007 and then decreased 3.3% to 19,140 for 2008 
(Table 1). During this period, 49 jurisdictions (45 states, two 
cities, Puerto Rico, and Guam) reported giardiasis cases. No 
reports were received from the five states (Indiana, Kentucky, 
Mississippi, North Carolina, and Texas) in which giardiasis is 
not a reportable disease.
For 2008, among jurisdictions reporting cases, incidence 
of giardiasis per 100,000 population ranged from 2.2 cases in 
Arizona to 33.8 cases in Vermont (Table 1; Figure 1). Vermont 
reported the greatest number of cases per 100,000 population 
for each of the 3 years of the reporting period. Northern states 
reported more cases annually per 100,000 population than 
southern states (Table 1; Figure 1).
Surveillance data displayed a bimodal age distribution, 
with the greatest number of reported cases occurring among 
children aged 1–4 and 5–9 years and adults aged 35–44 years 
(Figure 2). When reports for which a patient’s sex was missing 
or unknown were excluded, the percentage of cases reported 
to have occurred among males remained consistent at 56.2% 
(10,671 of 18,994) for 2006, 56.5% (11,069 of 19,585) for 
2007, and 56.7% (10,786 of 19,019) for 2008 (Table 2). 
The majority of cases for which data on race were available 
for 2006–2008 occurred among whites, followed by blacks, 
Asians/Pacific Islanders, and American Indians/Alaska Natives 
(Table 2). However, data on race were not included for 41.2%–
43.7% of total annual case reports. Although 7.2%–8.2% 
of patients for whom data on ethnicity were reported were 
identified as Hispanic, data on ethnicity were lacking for 
49.3%–52.2% of total annual case reports.
A twofold increase in reported giardiasis cases by onset 
of illness occurred during June–October compared with 
January–March (Figure 3). Age-specific analysis indicated 
a twofold increase in onset of illness during June–October 
among all age groups. This seasonality is particularly evident 
among children (Figure 4). The highest numbers of giardiasis 
cases were reported among children aged 1–4 and 5–9 years 
and adults aged 40–44 years (Figure 4). The incidence of giar-
diasis has remained relatively stable since it became nationally 
notifiable in 2002 (Figure 5). 
Discussion
National giardiasis surveillance data are used to assess the 
epidemiologic characteristics and disease burden of giardiasis in 
the United States. Following a gradual decline in case reports 
during 1996–2001 (33,34), the number of case reports and 
disease incidence appears to have stabilized, coinciding with the 
disease becoming nationally notifiable in 2002 (Figure 5).
Giardiasis is widespread geographically in the United States. The 
number of cases reported is higher in the northern states (Figure 1). 
However, because differences in giardiasis surveillance systems 
among states can affect the capability to detect cases, whether this 
finding is of biologic significance or only reflects differences in 
case detection or reporting is difficult to determine.
Although giardiasis affects persons in all age groups, the 
number of reported cases was highest among children aged 1–9 
years and adults aged 35–44 years. These data for younger age 
groups are consistent with reports published previously of giar-
diasis incidence being higher among younger children as well as 
contributing to transmission to their caregivers (e.g., child care 
facility staff, family members, and other household contacts) 
(2,33–35,39,40). Giardia was identified frequently as the cause 
of diarrhea among children examined in outpatient clinics (41), 
and transmission from ill children to household contacts has 
been documented in outbreak investigations (29,42).
The marked seasonality in the onset of illness occurring in 
early summer through early fall is not unexpected. A twofold 
increase in transmission of giardiasis occurred during the sum-
mer, coinciding with increased outdoor activities (e.g., camp-
ing and swimming). This increase likely reflects increased use 
of untreated water for drinking (e.g., lakes and rivers) while 
outdoors as well as increased use of community swimming 
(essentially communal bathing) venues by younger children 
during the summer months. In addition to animal contamina-
tion of surface water, transmission through use of surface water 
(e.g., lakes and rivers) and disinfected venues (e.g., swimming 
pools and water parks) is facilitated by the substantial number 
of Giardia cysts that can be shed by a single person (9); the 
extended periods of time that cysts can be shed (10); the low 
infectious dose (8); the moderate chlorine tolerance of Giardia 
(43); the prevalence of improper pool maintenance (i.e., insuf-
18 MMWR June 11, 2010
TABLE 1. Number and percentage* of giardiasis case reports, by state/area — National Notifiable Disease Surveillance System, 
United States, 2006–2008
2006 2007 2008
State/Area No. (%) Rate†
No. 
outbreak 
cases§ No. (%) Rate
No. 
outbreak 




Alabama 224 (1.2) 4.8 273 (1.4) 5.9 281 (1.5) 6.0
Alaska 113 (0.6) 16.5 5 79 (0.4) 11.6 108 (0.6) 15.7
Arizona 163 (0.8) 2.5 192 (1.0) 3.0 142 (0.7) 2.2
Arkansas 148 (0.8) 5.2 158 (0.8) 5.6 143 (0.7) 5.0
California 2,303 (12.0) 6.3 2,336 (11.8) 6.4 2,017 (10.5) 5.5
Colorado 554 (2.9) 11.2 6 580 (2.9) 12.0 4 564 (2.9) 11.4 1
Connecticut 307 (1.6) 8.8 370 (1.9) 10.6 334 (1.7) 9.5
Delaware 43 (0.2) 4.9 41 (0.2) 4.8 42 (0.2) 4.8
District of Columbia 69 (0.4) 11.7 74 (0.4) 12.6 72 (0.4) 12.2
Florida 1,165 (6.1) 6.4 156 1,268 (6.4) 7.0 83 1,391 (7.3) 7.6 82
Georgia 642 (3.3) 6.6 681 (3.4) 7.2 691 (3.6) 7.1
Hawaii 58 (0.3) 4.5 77 (0.4) 6.0 42 (0.2) 3.3
Idaho 191 (1.0) 12.5 1 224 (1.1) 15.0 9 211 (1.1) 13.8 1
Illinois 695 (3.6) 5.4 3 866 (4.4) 6.8 705 (3.7) 5.5
Indiana N¶   N   N   
Iowa 303 (1.6) 10.1 301 (1.5) 10.1 326 (1.7) 10.9
Kansas 198 (1.0) 7.1 184 (0.9) 6.6 2 162 (0.8) 5.8
Kentucky N   N   N   
Louisiana 87 (0.5) 2.0 139 (0.7) 3.2 150 (0.8) 3.4
Maine 192 (1.0) 14.6 197 (1.0) 15.0 188 (1.0) 14.3 1
Maryland 256 (1.3) 4.5 2 269 (1.4) 4.8 6 284 (1.5) 5.0 2
Massachusetts 621 (3.2) 9.6 605 (3.1) 9.4 12 678 (3.5) 10.4 3
Michigan 715 (3.7) 7.1 620 (3.1) 6.2 10 611 (3.2) 6.1 2
Minnesota 1,001 (5.2) 19.2 913 (4.6) 17.6 769 (4.0) 14.7
Mississippi N  N  N   
Missouri 548 (2.8) 9.3 515 (2.6) 8.8 468 (2.4) 7.9
Montana 104 (0.5) 10.8 113 (0.6) 11.8 93 (0.5) 9.6
Nebraska 122 (0.6) 6.8 161 (0.8) 9.1 210 (1.1) 11.8 1
Nevada 110 (0.6) 4.2 146 (0.7) 5.7 2 121 (0.6) 4.7
New Hampshire 26 (0.1) 2.0 33 (0.2) 2.5 164 (0.9) 12.5
New Jersey 476 (2.5) 5.5 96 403 (2.0) 4.7 115 520 (2.7) 6.0
New Mexico 80 (0.4) 4.0 119 (0.6) 6.1 5 107 (0.6) 5.4
New York** 2,311 (12.0) 11.9 32 2,122 (10.7) 10.9 24 2,133 (11.1) 10.9 33
 New York City 936 (4.9) 11.3 847 (4.3) 10.2 851 (4.4) 10.2
North Carolina N   N   N   
North Dakota 38 (0.2) 5.9 60 (0.3) 9.4 36 (0.2) 5.6 1
Ohio 809 (4.2) 7.0 5 826 (4.2) 7.2 7 904 (4.7) 7.9 5
Oklahoma 166 (0.9) 4.6 172 (0.9) 4.8 180 (0.9) 4.9
Oregon 417 (2.2) 11.0 9 462 (2.3) 12.4 455 (2.4) 12.0 4
Pennsylvania 825 (4.3) 6.6 47 758 (3.8) 6.1 58 879 (4.6) 7.1 31
Rhode Island 117 (0.6) 11.1 85 (0.4) 8.1 90 (0.5) 8.6
South Carolina 112 (0.6) 2.5 121 (0.6) 2.7 136 (0.7) 3.0 3
South Dakota 97 (0.5) 12.1 104 (0.5) 13.1 5 136 (0.7) 16.9 11
Tennessee 241 (1.3) 3.9 304 (1.5) 4.9 225 (1.2) 3.6
Texas N N N   
Utah 471 (2.4) 17.2 21 466 (2.4) 17.5 374 (2.0) 13.7
Vermont 193 (1.0) 31.1 1 171 (0.9) 27.5 210 (1.1) 33.8
Virginia 514 (2.7) 6.6 582 (2.9) 7.6 3 432 (2.3) 5.6
Washington 451 (2.3) 6.9 595 (3.0) 9.2 486 (2.5) 7.4
West Virginia 57 (0.3) 3.1 52 (0.3) 2.9 71 (0.4) 3.9 2
Wisconsin 587 (3.1) 10.4 9 555 (2.8) 9.9 523 (2.7) 9.3
Wyoming 38 (0.2) 7.1 49 (0.2) 9.4 49 (0.3) 9.2 5
Total 50 states 18,958 (98.5) 7.5 392 19,421 (98.1) 7.6 345 18,913 (98.8) 7.4 188
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ficient disinfection, filtration, and recirculation of water), 
particularly of children’s wading pools (44); the prevalence 
of Giardia in fecal material in pools (45); and documented 
transmission of Giardia infection among diapered children 
(28,42,46) who use swimming venues regularly. This seasonal 
variation also has been noted in state, Canadian provincial, 
and previous U.S. national surveillance data for giardiasis and 
cryptosporidiosis (33–35,39,40).
Among patients for whom data on sex were reported, a 
majority of cases occurred among males (Table 2). This might 
be attributable in part to sexual contact among men who have 
sex with men (16). However, the majority of cases occurred in 
males in nearly every age group (except those aged ≥65 years), 
which suggests the influence of other factors. 
Outbreaks have been linked to drinking water sources con-
taminated with Giardia. In 2007, a neighborhood outbreak of 
giardiasis in New Hampshire was linked to contamination of a 
ground water well used for drinking water by the community 
(30). Thirty-one confirmed or probable cases were identified 
and determined to be associated with drinking tap water. One 
of the groundwater wells supplying the community was dug in 
close proximity to surface water, a small stream, where evidence 
of beaver inhabitation was discovered. The well tested positive 
for fecal coliforms and was disconnected from the water sup-
ply, after which the outbreak declined. PCR testing was used 
to genotype the cases as assemblage B, a subtype that has not 
been reported previously in humans but has been found in 
beavers in nearby Massachusetts. Two beavers from the area 
tested negative for Giardia, but beavers could not be ruled out 
as the source because shedding of cysts is sporadic.
Although untreated or unfiltered drinking water is a risk fac-
tor for giardiasis, contaminated recreational water has also been 
implicated as a source of illnesses and outbreaks. In a study of 
sporadic giardiasis in England, swallowing water while swim-
ming and recreational contact with fresh water were both risk 
factors for contracting Giardia (18). An outbreak in Florida 
in 2006 at an interactive fountain was caused by Giardia and 
Cryptosporidium and resulted in illness among 57 persons over 
a 2-month period (47). Investigation of this outbreak revealed 
deficiencies in the design, maintenance, and operation of the 
interactive fountain as well as bather behavior (i.e., swimming 
while ill with diarrhea) that led to ongoing contamination of 
the interactive fountain.
Foodborne transmission of Giardia generally occurs by direct 
contamination by an infected food handler (27), the use of 
contaminated water in the preparation of food (48), or animal 
contamination of food (49). In a study of sporadic giardiasis in 
England, eating lettuce was associated with increased risk for 
giardiasis (18). The use of reclaimed wastewater for irrigation 
FIGURE 1. Incidence* of giardiasis, by state/area — National 











* Per 100,000 population. 
† Not a reportable disease in these states.
TABLE 1. (Continued) Number and percentage* of giardiasis case reports, by state/area — National Notifiable Disease Surveillance 
System,  United States, 2006–2008
2006 2007 2008
State/Area No. (%) Rate†
No. 
outbreak 
cases§ No. (%) Rate
No. 
outbreak 




Guam 5 (<0.1) 2.9 2 (<0.1) 1.2 0
Puerto Rico 276 (1.4) 7.0 1 371 (1.9) 9.4 1 227 (1.2) 5.7 1
Total 19,239 (100.0) — 393 19,794 (100.0) — 346 19,140 (100.0) — 189
Sources: Population estimates are from the Population Division, U.S. Census Bureau. Annual estimates of the resident population for the United States, 
regions, states, and Puerto Rico: April 1, 2001–July 1, 2008 (NST-EST 2008-01) available at http://www.census.gov/popest/states. Estimates of the New York 
City population are from annual estimates of the population for incorporated places over 100,000, ranked by July 1, 2005 Population: April 1, 2001–July 1, 
2008 (SUB-EST 2008-01) available at http://www.census.gov/popest/cities. Estimates of the population of Guam are from International Data Base (IDB) 
data access–spreadsheet available at http://www.census.gov/ipc/www/idbsprd.html.
 * Percentages might not total 100% because of rounding.
 † Per 100,000 population.
 § Number of cases linked to a known outbreak.
 ¶ Giardia is not a reputable condition in five states.
 ** New York State case reports include New York City.
20 MMWR June 11, 2010
is associated with the finding of Giardia cysts on fresh produce 
(50). The importance of food in the transmission of Giardia 
is highlighted by five giardiasis outbreaks during 2006–2007. 
In 2006, two confirmed foodborne outbreaks occurred in 
California and New York (26). In California, 48 ill persons had 
attended the same church event, and in New York, eight patients 
TABLE 2. Number and percentage* of giardiasis case reports, by selected demographic characteristics — National Notifiable Disease 
Surveillance System, United States 2006–2008
2006 2007 2008 
Characteristic No.         (%) No.         (%) No.         (%)
Sex 
Male   10,671   (55.5)   11,069   (55.9) 10,786   (56.4)
Female   8,323   (43.3)   8,516  ( 43.0) 8,233   (43.0)
Unknown/Missing     245     (1.3)     209     (1.1) 121     (0.6)
Total 19,239 (100.0) 19,794 (100.0) 19,140 (100.0)
Race
American Indian/Alaska Native 86     (0.4) 79      (0.4) 70     (0.4)
Asian/Pacific Islander 726     (3.8) 878     (4.4) 1,203     (6.3)
Black 1,231     (6.4) 1,517     (7.7) 1,333     (7.0)
White 8,063   (41.9) 8,089   (40.9) 7,895   (41.2)
Other 720     (3.7) 684     (3.5) 752     (3.9)
Unknown/Missing 8,413   (43.7) 8,547   (43.2) 7,887   (41.2)
Total 19,239 (100.0) 19,794 (100.0) 19,140 (100.0)
Ethnicity
Hispanic 1,584     (8.2) 1,430     (7.2) 1,436     (7.5)
Non-Hispanic 7,784   (40.5) 8,033   (40.6) 8,277   (43.2)
Unknown/Missing 9,871   (51.3) 10,331   (52.2) 9,427   (49.3)
Total 19,239 (100.0) 19,794 (100.0) 19,140 (100.0)
* Totals might not add up to 100% because of rounding. 






















* N = 58,186; age group unknown for 1,083 cases.
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became ill after a restaurant-catered lunch at a school. A third 
suspected outbreak occurred in Florida, where four patients had 
eaten at the same restaurant. In 2007, two confirmed foodborne 
outbreaks occurred in Missouri and Vermont (26). In Missouri, 
15 attendees at a catered event became ill after eating chicken 
parmesan and lettuce salads. The caterer was not licensed and 
worked out of her home (26). In Vermont, 36 boys became ill 
at a summer camp with no running water or electricity. The 
source of the outbreak was not identified (26).
The relative importance of zoonotic transmission of Giardia, 
either directly or indirectly (e.g., through water or food contami-
nation) is unknown. Cattle have been suspected to contribute 
to the contamination of drinking water with Giardia as a result 
of farm run-off and the land application of animal waste. In the 
United States and Australia, livestock are infected predominately 
with the bovine-specific genetic assemblage E (which is not infec-
tive to humans). Assemblage A (which is a human pathogen) can 
be found in a small proportion of cattle, but investigations of 
contaminated water supplies typically incriminate effluent from 
human waste as the source of contamination (12). However, as the 
New Hampshire outbreak demonstrates, other potential zoonotic 
sources exist in wildlife. In a molecular study, the same genetic 
assemblage B was identified in samples from humans, muskrats, 
beavers, and rabbits, suggesting the potential for zoonotic trans-
mission or water contamination from these species (51).
Household pets also represent a potential source of zoonotic 
transmission. Giardia is the most prevalent intestinal parasite 
in otherwise healthy pet dogs in Australia; 9.4% of dogs in a 
study tested positive on fecal specimens; assemblages C and D 
were identified most frequently (52). A study in India identified 
identical assemblages (A and B) in humans and their pet dogs 
(53). Because of poor hygiene in the village, including the dogs’ 
access to human feces, whether the infection was of zoonotic 
or anthroponotic transmission was unclear. Ongoing advances 
in molecular epidemiology will increase understanding of the 
importance of animals as a risk factor for giardiasis (54).
FIGURE 4. Number* of giardiasis case reports, by selected age 
group† and date of illness onset — National Notifiable Disease 




















* N = 9,921. 
† The three age groups (1–4, 5–9, and 40–44 years) with the highest num-
bers of giardiasis case reports are presented. All age groups exhibited a 
twofold or greater increase during summer months.
FIGURE 5. Incidence* of giardiasis, by year — National 


















* Per 100,000 population. 
† N = 354,385.
§ First year with use of assigned reporting number.
FIGURE 3. Number* of giardiasis case reports, by date of 
illness onset — National Notifiable Disease Surveillance 













* N = 58,186; onset date was unknown for 28,650 cases.
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Despite the zoonotic potential, infected human waste is the 
greatest known risk factor for infection with Giardia, whether 
transmission is through direct fecal-oral contact or indirectly 
through ingestion of fecally contaminated water. In a study of 
sporadic giardiasis in New Zealand, exposure to human waste 
was a significant risk factor, specifically exposure to diaper 
changing and occupational exposure to human waste (55). The 
study also determined that housewives and nursing mothers 
were at increased risk for giardiasis compared with other social 
groups, which is consistent with increased risk for exposure 
to diapers (55). Children attending child care facilities are at 
increased risk for giardiasis (15), and outbreaks have occurred 
in child care facilities, leading to infections among caregivers 
and household members (28,56,57). 
Giardiasis (as with all diseases caused by enteric pathogens) 
is likely underreported because 1) not all infected persons are 
symptomatic, 2) those who are symptomatic do not always 
seek medical care (58,59), 3) health-care providers do not 
always include laboratory diagnostics in their evaluation of 
non-bloody diarrheal diseases (58), 4) case reports are not 
always completed for positive laboratory results or forwarded 
to public health officials (60), and 5) giardiasis is not a report-
able disease in five states. 
Its low infectious dose, protracted communicability, and 
moderate chlorine tolerance make Giardia ideally suited for 
transmission through drinking and recreational water, food, 
and person-to-person contact. Strategies to reduce the inci-
dence of giardiasis have focused on reducing waterborne and 
person-to-person transmission. The Environmental Protection 
Agency (EPA) enacted the Surface Water Treatment Rule 
(SWTR) in 1989 and the Interim Enhanced SWTR in 1998 
(21). These regulations have decreased the number of giardiasis 
outbreaks associated with community drinking water systems 
(20–24). In 2006, EPA finalized the Ground Water Rule to 
address contamination of public ground water (well) systems, 
which is likely to reduce the number of groundwater-associated 
outbreaks of giardiasis. Person-to-person transmission of 
Giardia is difficult to interrupt in a systematic fashion, par-
ticularly in childcare settings (56). Adherence to appropriate 
infection control (e.g., exclusion of children ill with diarrhea, 
hand washing, diaper changing, and separation of ill children) 
policies is recommended for controlling giardiasis, and other 
enteric pathogens, in these group settings (57). 
Limitations
The data provided in this report are subject to several limita-
tions, including likely underreporting of cases, lack of informa-
tion on race and ethnicity on the majority of case-reports, and 
absence of information on risk factors or attributable fractions by 
exposure types. Despite these limitations, the data in this report 
provide the only national overview of giardiasis available.
Conclusion
Continued efforts to reduce risk and improve diagnosis and 
reporting of giardiasis are needed to decrease the transmission 
of giardiasis in the United States. Prevention measures (Box 1) 
and measures to improve surveillance for giardiasis and increase 
understanding of its epidemiology and the associated disease 
burden (Box 2) have been recommended. Additional informa-
tion about giardiasis is available at http://www.cdc.gov/ncidod/
dpd/parasites/giardiasis/factsht_giardia.htm.
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Avoid water that might be contaminated.
Do not swallow water while swimming in swimming •	
pools, spas, interactive fountains, lakes, rivers, springs, 
ponds, streams, or the ocean.
Do not drink untreated water from lakes, rivers, springs, •	
ponds, streams, or shallow wells.
Do not drink inadequately treated water or ice made •	
from water during communitywide outbreaks caused 
by contaminated drinking water.
Do not use or drink inadequately treated water or use •	
ice when traveling in countries where the water supply 
might be unsafe.
If the safety of drinking water is in doubt (e.g., outbreak, •	
poor sanitation, or lack of water treatment systems),
drink bottled water –
disinfect water by heating it to a rolling boil for 1  –
minute, or
use a filter that has been tested and rated by National  –
Safety Foundation (NSF) Standard 53 or NSF 
Standard 58 for cyst and oocyst reduction; filtered 
water will need additional treatment to kill or inac-
tivate bacteria and viruses. 
Information about water fi lters is available at 
http://www.cdc.gov/crypto/gen_info/filters.html. 
Avoid eating food that might be contaminated.
Use safe, uncontaminated water to wash all food that is •	
to be eaten raw.
After washing vegetables and fruit in safe, uncontami-•	
nated water, peel them before eating them raw. 
Avoid eating uncooked foods when traveling in countries •	
with poor water treatment and food sanitation. 
Information about how to prevent illnesses while travel-
ing is available at http://wwwnc.cdc.gov/travel/content/
safe-food-water.aspx.
Prevent contact and contamination with feces during sex.
Use a barrier during oral-anal sex.•	
Wash hands immediately after handling a condom used •	
during anal sex and after touching the anus or rectal area.
Practice good hygiene.
Everywhere•	
Wash hands with soap and water for at least 20  –
seconds, rub hands together vigorously, and scrub 
all surfaces
before preparing or eating food, º
after using the toilet, º
after changing diapers or cleaning up a child who  º
has used the toilet,
before and after tending to someone who is ill  º
with diarrhea, and 
after handling an animal or its waste. º
Additional information about hygiene is available at http://
www.cdc.gov/healthywater/hygiene.  
At child care facilities•	
To reduce risk for disease transmission, exclude chil- –
dren with diarrhea from child care settings until the 
diarrhea has stopped.
At recreational water venues•	
Protect others by not swimming if while experiencing  –
diarrhea (this is essential for children in diapers and 
aquatics staff). 
Shower before entering the water. –
Wash children thoroughly (especially their bottoms)  –
with soap and water after they use the toilet or their 
diapers are changed and before they enter the water.
Take children on frequent bathroom breaks and check  –
their diapers often.
Change diapers in the bathroom, not at the  –
poolside.
Additional information about recreational water illnesses 
and how to stop them from spreading is available at http://
www.cdc.gov/healthywater/swimming.
Around animals•	
Minimize contact with the stool of all animals, par- –
ticularly young animals.
When cleaning up animal feces, wear disposable  –
gloves, and always wash hands when finished.
Wash hands after any contact with animals or their  –
living areas.
Outside•	
Wash hands after gardening, even if wearing gloves. –
BOX 1. CDC recommendations to prevent and control giardiasis 
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